NLS Pharmaceutics AG (NLSP)
NLSP Stock Price Chart
Explore NLS Pharmaceutics AG interactive price chart. Choose custom timeframes to analyze NLSP price movements and trends.
NLSP Company Profile
Discover essential business fundamentals and corporate details for NLS Pharmaceutics AG (NLSP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
29 Jan 2021
Employees
6.00
Website
https://nlspharma.comCEO
Alexander Zwyer
Description
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company was incorporated in 2015 and is based in Zurich, Switzerland.
NLSP Financial Timeline
Browse a chronological timeline of NLS Pharmaceutics AG corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 15 Aug 2025
Earnings released on 16 May 2025
Earnings released on 18 Oct 2024
Stock split effective on 27 Sept 2024
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2024
EPS came in at -$0.00 surpassing the estimated -$8.40 by +100.00%.
Earnings released on 30 Jun 2023
EPS came in at -$0.20 surpassing the estimated -$6.80 by +97.07%.
Earnings released on 5 May 2023
EPS came in at -$0.29 surpassing the estimated -$12.00 by +97.55%.
Earnings released on 11 Oct 2022
EPS came in at -$0.54 .
Earnings released on 24 Mar 2022
EPS came in at -$0.50 surpassing the estimated -$13.80 by +96.39%.
Earnings released on 28 Sept 2021
EPS came in at -$0.42 .
Earnings released on 14 May 2021
EPS came in at -$0.34 surpassing the estimated -$6.80 by +95.03%.
NLSP Stock Performance
Access detailed NLSP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.